SI0970073T1 - Process for preparing eprosartan - Google Patents

Process for preparing eprosartan

Info

Publication number
SI0970073T1
SI0970073T1 SI9830722T SI9830722T SI0970073T1 SI 0970073 T1 SI0970073 T1 SI 0970073T1 SI 9830722 T SI9830722 T SI 9830722T SI 9830722 T SI9830722 T SI 9830722T SI 0970073 T1 SI0970073 T1 SI 0970073T1
Authority
SI
Slovenia
Prior art keywords
preparing eprosartan
eprosartan
preparing
Prior art date
Application number
SI9830722T
Other languages
English (en)
Slovenian (sl)
Inventor
Joseph Robert Flisak
Li Liu
Clifford S. Labaw
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of SI0970073T1 publication Critical patent/SI0970073T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
SI9830722T 1997-02-14 1998-02-13 Process for preparing eprosartan SI0970073T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3819597P 1997-02-14 1997-02-14
EP98906229A EP0970073B1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan
PCT/US1998/002412 WO1998035963A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (1)

Publication Number Publication Date
SI0970073T1 true SI0970073T1 (en) 2005-02-28

Family

ID=21898583

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830722T SI0970073T1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Country Status (41)

Country Link
US (1) US6172237B1 (xx)
EP (1) EP0970073B1 (xx)
JP (1) JP4537499B2 (xx)
KR (1) KR100573638B1 (xx)
CN (1) CN1085208C (xx)
AP (1) AP1128A (xx)
AR (1) AR011125A1 (xx)
AT (1) ATE280765T1 (xx)
AU (1) AU730383B2 (xx)
BG (1) BG63804B1 (xx)
BR (1) BR9808664A (xx)
CA (1) CA2281708C (xx)
CO (1) CO4950550A1 (xx)
CY (1) CY2555B1 (xx)
CZ (1) CZ296349B6 (xx)
DE (1) DE69827240T2 (xx)
DK (1) DK0970073T3 (xx)
EA (1) EA001659B1 (xx)
EG (1) EG23935A (xx)
ES (1) ES2231963T3 (xx)
HU (1) HU228781B1 (xx)
ID (1) ID23181A (xx)
IL (1) IL131309A (xx)
IN (2) IN187999B (xx)
MA (1) MA24470A1 (xx)
MY (1) MY118704A (xx)
NO (1) NO317194B1 (xx)
NZ (1) NZ337180A (xx)
OA (1) OA11146A (xx)
PE (1) PE59299A1 (xx)
PL (1) PL192838B1 (xx)
PT (1) PT970073E (xx)
RO (1) RO119719B1 (xx)
SA (1) SA98190082B1 (xx)
SI (1) SI0970073T1 (xx)
SK (1) SK285036B6 (xx)
TR (1) TR199901936T2 (xx)
TW (1) TW399050B (xx)
UA (1) UA54487C2 (xx)
WO (1) WO1998035963A1 (xx)
ZA (1) ZA981207B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008078330A1 (en) * 2006-12-27 2008-07-03 Hetero Drugs Limited Improved process for eprosartan
EP2295431A3 (en) * 2007-07-25 2011-08-03 Hetero Drugs Limited Substantially pure eprosartan free base
EP2181109A4 (en) * 2007-07-25 2011-08-03 Hetero Drugs Ltd CRYSTALLINE PARTICLES OF EPROSARTAN MESYLATE AND PROCESS FOR PREPARING PURE EPROSARTAN
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
US20110054186A1 (en) * 2008-03-31 2011-03-03 Hetero Research Foundation Process for eprosartan intermediate
WO2010023688A2 (en) * 2008-08-25 2010-03-04 Matrix Laboratories Limited An improved process for the preparation of eprosartan
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
WO2011051975A1 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
MX9605794A (es) * 1994-05-20 1997-12-31 Smithkline Beecham Corp Intermediario para preparar un compuesto farmaceuticamente activo.

Also Published As

Publication number Publication date
DK0970073T3 (da) 2005-02-21
PT970073E (pt) 2005-02-28
US6172237B1 (en) 2001-01-09
CA2281708A1 (en) 1998-08-20
PL335075A1 (en) 2000-04-10
ID23181A (id) 2000-03-23
JP4537499B2 (ja) 2010-09-01
ATE280765T1 (de) 2004-11-15
DE69827240D1 (de) 2004-12-02
SK285036B6 (sk) 2006-05-04
AP9901620A0 (en) 1999-09-30
AP1128A (en) 2002-12-06
HUP0001994A3 (en) 2001-07-30
CN1247539A (zh) 2000-03-15
HUP0001994A2 (hu) 2001-06-28
KR100573638B1 (ko) 2006-04-26
IL131309A (en) 2002-09-12
DE69827240T2 (de) 2005-10-13
NO993913D0 (no) 1999-08-13
TR199901936T2 (xx) 2000-04-21
KR20000071007A (ko) 2000-11-25
EP0970073A1 (en) 2000-01-12
OA11146A (en) 2003-04-16
TW399050B (en) 2000-07-21
PE59299A1 (es) 1999-09-09
AU730383B2 (en) 2001-03-08
IL131309A0 (en) 2001-01-28
EA199900740A1 (ru) 2000-02-28
JP2001510466A (ja) 2001-07-31
CA2281708C (en) 2007-08-14
HU228781B1 (en) 2013-05-28
EP0970073B1 (en) 2004-10-27
IN187999B (xx) 2002-08-03
UA54487C2 (uk) 2003-03-17
AU6150898A (en) 1998-09-08
MY118704A (en) 2005-01-31
IN192743B (xx) 2004-05-15
NO993913L (no) 1999-08-13
BG103650A (en) 2000-06-30
BR9808664A (pt) 2000-07-11
BG63804B1 (bg) 2003-01-31
NO317194B1 (no) 2004-09-13
ES2231963T3 (es) 2005-05-16
EP0970073A4 (en) 2001-01-24
AR011125A1 (es) 2000-08-02
CZ285299A3 (cs) 2000-02-16
CO4950550A1 (es) 2000-09-01
CY2555B1 (en) 2008-07-02
MA24470A1 (fr) 1998-10-01
CZ296349B6 (cs) 2006-02-15
NZ337180A (en) 2000-11-24
EA001659B1 (ru) 2001-06-25
SA98190082B1 (ar) 2006-08-20
PL192838B1 (pl) 2006-12-29
CN1085208C (zh) 2002-05-22
RO119719B1 (ro) 2005-02-28
SK108799A3 (en) 2000-05-16
WO1998035963A1 (en) 1998-08-20
EG23935A (en) 2008-01-14
ZA981207B (en) 1998-11-12

Similar Documents

Publication Publication Date Title
HUP0004239A2 (en) Process for synthesizing phosphodiesters
CY2551B1 (en) Process for preparing eprosartan
CY2555B1 (en) Process for preparing eprosartan
IL134059A0 (en) Process for preparing aminoarylacetylenes
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
IL126184A (en) Process for preparing pentafluoropentanol
IL133288A (en) Process for preparing 3-isochromanone
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
GB9810502D0 (en) Process for preparing distrylbiphenyl compounds
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
GB9800066D0 (en) Process for preparing dibenzocycycloheptene compounds
IL130950A0 (en) Process for preparing carboxamido-4- azasteroids
ZA987025B (en) Process for preparing 1-pyruvyl-L-proline
GB9825422D0 (en) Process for preparing pollyketones
GB9901721D0 (en) Process for preparing 4-tert-Butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
GB9809786D0 (en) Process for preparing 4-tert-Butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
ZA982141B (en) Process for preparing 2H-1-Benzopyrans.
HUP0002670A3 (en) Process for preparing etoposide
SI1021452T1 (en) Process for synthesizing phosphodiesters